Nutex Health Inc. - Common Stock, $0.001 par value (NUTX)

CUSIP: 67079U306

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
6,864,898
Total 13F shares
906,750
Share change
+253,342
Total reported value
$28,734,542
Price per share
$31.69
Number of holders
41
Value change
+$7,911,215
Number of buys
24
Number of sells
11

Security key

67079U306

Report period

Q4 2024

Institutions

41

Top holders

10

Top shareholders of NUTX - Nutex Health Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.3%
91,962
$1,995,576 30 Sep 2024
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
1.1%
72,785
$1,579,435 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
1%
69,556
$1,509,366 30 Sep 2024
13F
ONE PLUS ONE WEALTH MANAGEMENT, LLC
13F
Company
0.55%
37,541
$814,640 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
0.45%
30,741
$667,080 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.44%
30,299
$657,610 30 Sep 2024
13F
TRUIST FINANCIAL CORP
13F
Company
0.42%
29,116
$631,817 30 Sep 2024
13F
Legato Capital Management LLC
13F
Company
0.36%
24,972
$541,892 30 Sep 2024
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0.33%
22,775
$494,218 30 Sep 2024
13F
AVANTAX ADVISORY SERVICES, INC.
13F
Company
0.23%
16,017
$347,569 30 Sep 2024
13F
STATE STREET CORP
13F
Company
0.15%
10,357
$224,747 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.14%
9,898
$214,787 30 Sep 2024
13F
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.13%
8,680
$400,000 30 Sep 2024
13F
Beaird Harris Wealth Management, LLC
13F
Company
0.05%
3,200
$69,440 30 Sep 2024
13F
CITIGROUP INC
13F
Company
0.03%
2,398
$52,037 30 Sep 2024
13F
UBS Group AG
13F
Company
0.02%
1,497
$32,485 30 Sep 2024
13F
WealthCollab, LLC
13F
Company
0.01%
845
$18,337 30 Sep 2024
13F
NewEdge Advisors, LLC
13F
Company
0.01%
401
$8,703 30 Sep 2024
13F
Larson Financial Group LLC
13F
Company
0.01%
386
$8,376 30 Sep 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
281
$6,098 30 Sep 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0%
142
$3,000 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
130
$2,821 30 Sep 2024
13F
IAG Wealth Partners, LLC
13F
Company
0%
100
$2,170 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0%
97
$2,104 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
31
$673 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0%
27
$586 30 Sep 2024
13F
ATWOOD & PALMER INC
13F
Company
0%
13
$283 30 Sep 2024
13F
Scissortail Wealth Management, LLC
13F
Company
0%
2
$210,924 30 Sep 2024
13F
DANSKE BANK A/S
13F
Company
0%
2
$43 30 Sep 2024
13F
Sunbelt Securities, Inc.
13F
Company
0%
1
$22 30 Sep 2024
13F
Micro Hospital Holding LLC
3/4/5
10%+ Owner
class O/S missing
267,728,389
$60,506,616 01 Apr 2022
Dominis-Embree AHA Investor, LLC
3/4/5
10%+ Owner
class O/S missing
6,473,483
$1,463,007 26 Feb 2021
Premier Macy Management Holdings, LLC
3/4/5
10%+ Owner
class O/S missing
41,964,832
12 Dec 2022
Matthew Stephen Young
3/4/5
Director
class O/S missing
42,134,210
$9,522,331 01 Apr 2022
Dr. Danniel Stites
3/4/5
Director
class O/S missing
5,355,375
$1,210,315 01 Apr 2023
Robert Chan
3/4/5
Director
class O/S missing
4,389,691
$992,070 25 Feb 2021
Mark Fawcett
3/4/5
Director
mixed-class rows
365,977
mixed-class rows
$296,741 25 Feb 2021
Anh Nguyen
3/4/5
President of subsidiary
class O/S missing
683,134
$154,388 01 Oct 2021
Michael Bowen
3/4/5
Retired CFO
class O/S missing
437,105
$98,786 14 Sep 2022
Lawrence Schimmel
3/4/5
Chief Medical Information Off
class O/S missing
263,444
$59,538 02 Apr 2022
John J. Waters
3/4/5
Director
class O/S missing
196,262
$44,355 18 May 2023
Mitchell Creem
3/4/5
Director
class O/S missing
81,746
$18,475 14 Jun 2023
Andrew Barnett
3/4/5
EVP of Corp Development
class O/S missing
150,000
01 Apr 2022
Frederick Sternberg
3/4/5
President of subsidiary
class O/S missing
75,000
01 Apr 2022

Institutional Holders of Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) as of Q4 2024

As of 31 Dec 2024, Nutex Health Inc. - Common Stock, $0.001 par value (NUTX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 906,750 shares. The largest 10 holders included Topline Capital Management, LLC, VANGUARD GROUP INC, ESSEX INVESTMENT MANAGEMENT CO LLC, AMERICAN CENTURY COMPANIES INC, Ancora Advisors LLC, MARSHALL WACE, LLP, ONE PLUS ONE WEALTH MANAGEMENT, LLC, TRUIST FINANCIAL CORP, DRIVE WEALTH MANAGEMENT, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
28
Q4 2024 holders
41
Holder diff
13
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .